Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
There is an urgent need to evaluate interventions that can prevent the infection with
SARS-CoV 2 of healthcare workers at risk. Melatonin is an inexpensive and safe product with
protective effect in both bacterial and viral infections likely due to its anti-inflammatory
and anti-oxidative effects. This randomized controlled trial seeks to evaluate is efficacy as
a prophylaxis in healthcare workers exposed to the virus in their clinical practice.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz